Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

   
   

A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulf- ate, or a salt thereof, and a second active agent comprising an anticholinergic bronchodilator for the treatment of asthma, chronic obstructive pulmonary disease, or any other respiratory disease. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or any other respiratory disease.

Une composition pharmaceutique ou vétérinaire, comporte un premier agent actif choisi parmi un dehydroepiandrosterone et/ou le dehydroepiandrosterone-sulf- a mangé, ou un sel en, et un deuxième agent actif comportant un bronchodilateur anticholinergique pour le traitement de l'asthme, de la maladie pulmonaire obstructive chronique, ou de n'importe quelle autre maladie respiratoire. La composition est fournie dans diverses formulations et sous forme de kit. Les produits de ce brevet sont appliqués à la prophylaxie et au traitement de l'asthme, de la maladie pulmonaire obstructive chronique, ou de n'importe quelle autre maladie respiratoire.

 
Web www.patentalert.com

< Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

< Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases

> Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists

> Pharmaceutical formulations comprising N,N'-disubstituted piperazine compounds

~ 00162